Mental Health Clinics in Pinebluff, NC Accepting Medicare
3 Mental Health Clinics found. Showing 1 - 3
 Woodland House Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 110 E Boston Ave, Pinebluff, NC 28373 Phone: 336-495-2700 |
Moore Psr Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 110 E Boston Ave, Pinebluff, NC 28373 Phone: 910-281-5327 |
Moore Psr Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 110 E Boston Ave, Pinebluff, NC 28373 Phone: 910-281-5327 |
News Archive
Freeland Systems prohibited from selling Kardia Health Systems' software and customer lists
Today, the United States District Court enjoined Freeland Systems, LLC, from conducting a sale of Kardia Health Systems' (Kardia) software and customer lists developed since May 2008.
Higher physical activity associated with improved mood
Increasing one's level of physical activity may be an effective way to boost one's mood, according to a new study from a team including scientists at Johns Hopkins Bloomberg School of Public Health in collaboration with the National Institute of Mental Health Intramural Research Program.
"HiCy" drug regimen reverses multiple sclerosis symptoms in selected patients
A short-term, very-high dose regimen of the immune-suppressing drug cyclophosphamide seems to slow progression of multiple sclerosis (MS) in most of a small group of patients studied and may even restore neurological function lost to the disease, Johns Hopkins researchers report. The findings in nine people, most of whom had failed all other treatments, suggest new ways to treat a disease that tends to progress relentlessly.
Durata completes target enrollment in dalbavancin Phase 3 trial for ABSSSI
Durata Therapeutics today announced that it has completed its target enrollment for DISCOVER 2 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response"), the second global, Phase 3 clinical trial of Durata's lead product candidate, dalbavancin, under investigation for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive bacteria.
› Verified 6 days ago